Accessibility Menu
Odyssey Health logo

Odyssey Health(OTC) ODYY

Market Cap$444.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-98%
5 Year-99%
1 Year-82%
1 Month-35%
$0.00
-26.67%
-0.00Today
Odyssey Health last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-29
Odyssey Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-31.25%USD 0.012026-07-22
1 month-35.29%USD 0.012026-06-29
3 month-92.32%USD 0.062026-04-30
Year to date-86.63%USD 0.032025-12-31
1 year-82.19%USD 0.022025-07-29
3 year-96%USD 0.112023-07-28
5 year-99.14%USD 0.512021-07-30
Since inception-98.24%USD 0.252017-08-23

Odyssey Health Financials at a Glance

Market Cap

$444.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$3.57M

EPS (TTM)

-$0.03

P/E Ratio

-0.13

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Price

$0.00

Volume

72,624

Open

$0.01

Previous Close

$0.00

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.13

Estimated Earnings Date

Apr 30, 2023

ODYY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Odyssey Health

Odyssey Health develops medical devices to address urgent health needs. Its products aim to help people in emergencies and monitor heart health. The company focuses on solutions for both individuals and healthcare providers.

Gadgets and Good Deeds: What Odyssey Health Makes

  • CardioMap: Heart monitoring device for early detection of heart issues; targets clinics and individuals. (0% of revenue, as no sales reported)
  • Save A Life: Choking rescue device designed for emergency use in homes, schools, and public spaces. (0% of revenue)
  • Neurosteroid Compounds: PRV-001 and PRV-002, drug candidates for concussion and rare brain disorders; sold to Oragenics in December 2023. (0% of revenue)

Plot Twists and Pivots: Growth & Expansion Moves

  • Sold PRV-001 and PRV-002 drug assets to Oragenics in December 2023.
  • Secured $300,000 in new funding from an accredited investor in August 2024.
  • Shifted focus to device development after divesting drug candidates in 2023.
  • No global market entries or major acquisitions reported since 2021 IPO.

Why Odyssey Health Is a Bit Different

Odyssey Health holds intellectual property for its devices but has no products on the market. The company outsources product development and manufacturing to third parties. It faces operational challenges due to limited staff and funding.

Five Things You Need to Know

  • Revenue was $0 in Q3 2025, unchanged for three years.
  • Net loss was $251,743 in Q3 2025, improved 70.1% from Q3 2024.
  • Cash at April 30, 2025, was $3,186, down from $66,014 a year earlier.
  • Total assets fell to $164,508 at April 30, 2025, from $586,146 in July 2024.
  • Current liabilities rose to $6.87 million at April 30, 2025, up from $5.92 million in July 2024.

Bottom Line

Odyssey Health has shifted from drug development to medical devices, but faces ongoing financial and operational hurdles. Its future depends on securing new funding and bringing products to market.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

2

CEO

Joseph Michael Redmond

Website

www.odysseyhealthinc.com

Headquarters

Las Vegas, NV 89102, US

ODYY Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

41.46%

Return on Capital

N/A

Return on Assets

-955.40%

Earnings Yield

-7.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$444.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

100.97M

Volume

72.62K

Avg. Volume

176.67K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$937.46K

EBITDA

$175.72K

Operating Cash Flow

-$934.98K

Capital Expenditure

$0.00

Free Cash Flow

-$934.98K

Cash & ST Invst.

$297.81K

Total Debt

$2.64M

Odyssey Health Performance Analysis

Odyssey Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-07-31USD 0N/A
20232023-07-31USD 0N/A
20242024-07-31USD 0N/A
20252025-07-31USD 0N/A
Odyssey Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-07-31N/A
Q12025-10-31N/A
Q22026-01-31N/A
Q32026-04-30N/A
Odyssey Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-07-31USD -0.09-47.3%
20232023-07-31USD -0.07-24.6%
20242024-07-31USD -0.01-87.0%
20252025-07-31USD -0.0278.5%
Odyssey Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-07-31-8.3%
Q12025-10-31-76.9%
Q22026-01-31-626.1%
Q32026-04-30121.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$444.30KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$222.15K

N/A

Employees

2

N/A

Net Income

$765.89K

+404.2%

EBITDA

$95.12K

+150.0%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$297.81K

+9247.3%

Total Debt

$2.64M

+33.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$2.64M

+33.7%

Return on Assets

-9.55%

N/A

Return on Invested Capital

9.62%

N/A

Free Cash Flow

-$318.52K

-7863.0%

Operating Cash Flow

-$318.52K

-7863.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMTHAnTix Holdings, Inc.
$0.00+0.00%
GVDIGolden Valley Development, Inc
$0.01+0.00%
ADMTADM Tronics Unlimited, Inc.
$0.04+0.00%
AIMLFAI/ML Innovations Inc.
$0.03+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$19.63-0.20%
NOKNokia
$8.41-0.06%
SKHYSK Hynix
$126.79-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About ODYY

What is the current price of Odyssey Health?

Odyssey Health is trading at $0.00 per share.

What is the 52-week range for Odyssey Health?

Over the past 52 weeks, Odyssey Health has traded between $0.00 and $0.13.

How much debt does Odyssey Health have?

As of the most recent reporting period, Odyssey Health reported total debt of $2.64M.

How much cash does Odyssey Health have on hand?

Odyssey Health reported $297.81K in cash and cash equivalents in its most recent financial results.

What is Odyssey Health’s dividend yield?

Odyssey Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services